Oral and general health-related quality of life in patients treated for oral cancer compared to control group

Table 5 Association between clinical and treatment data and health-related quality of life and oral health-related quality of life in patients survivors of oral cancer (n = 142)

Variable	PCS ^a	MCS ^b	OHIP-14 ^c	OIDP ^d
Variable	Mean ± de	Mean ± de	Mean ± de	Mean ± de
Location
Oral	47.5 ± 11.6	36.9 ± 9.0	18.3 ± 11.9	22.1 ± 18.0
Oropharynx	46.5 ± 10.5	35.4 ± 9.0	23.7 ± 9.8	28.7 ± 20.3
Oropharynx	p ^e = 0.730	p ^e = 0.520	p ^g = 0.043	p ^g = 0.155
Clinical stage
I-II	49.1 ± 11.9	36.5 ± 10.0	14.8 ± 10.3	17.0 ± 15.7
III-IV	46.2 ± 11.0	36.1 ± 8.1	22.0 ± 11.9	27.4 ± 19.0
III-IV	p ^e = 0.133	p ^e = 0.768	p ^g = <0.001	p ^g = <0.001
Follow-up (years)
0.5-5	41.5 ± 1.3	46.0 ± 1.2	19.5 ± 1.3	23.4 ± 1.9
6-10	43.5 ± 2.1	44.7 ± 2.3	16.5 ± 1.7	20.1 ± 2.7
11-20	43.7 ± 2.8	47.0 ± 2.2	20.8 ± 3.2	25.6 ± 5.8
11-20	p ^f = 0.614	p ^f = 0.780	p ^h = 0.454	p ^h = 0.743
Treatment
Surgery	47.5 ± 12.1	36.7 ± 9.6	16.1 ± 11.6	19.0 ± 18.4
Combined treatment	47.3 ± 10.8	36.8 ± 8.2	22.0 ± 11.3	26.7 ± 17.6
Combined treatment	p ^e = 0.897	p ^e = 0.950	p ^g = 0.002	p ^g = 0.002

^aPCS: Physical Component Summary; ^bMCS: Mental Component Summary; ^cOHIP-14: Oral Health Impact Profile; ^dOIDP: Oral Impacts on Daily Performances; ^eStudent’s t test; ^fANOVA test; ^gMann–Whitney U test; ^hKruskal Wallis test.

ISSN: 1477-7525